Longitudinal analysis of extracellular vesicle-associated tissue factor activity in cancer patients
- 23 July 2020
- journal article
- letter
- Published by Elsevier BV in Thrombosis Research
- Vol. 195, 215-218
- https://doi.org/10.1016/j.thromres.2020.07.041
Abstract
No abstract availableKeywords
This publication has 10 references indexed in Scilit:
- Effect of chemotherapy and longitudinal analysis of circulating extracellular vesicle tissue factor activity in patients with pancreatic and colorectal cancerResearch and Practice in Thrombosis and Haemostasis, 2020
- Cancer-associated pathways and biomarkers of venous thrombosisBlood, 2017
- Podoplanin expression in primary brain tumors induces platelet aggregation and increases risk of venous thromboembolismBlood, 2017
- Cancer-associated venous thromboembolism: Burden, mechanisms, and managementThrombosis and Haemostasis, 2017
- Measurement of microparticle tissue factor activity in clinical samples: A summary of two tissue factor-dependent FXa generation assaysThrombosis Research, 2016
- Longitudinal analysis of hemostasis biomarkers in cancer patients during antitumor treatmentJournal of Thrombosis and Haemostasis, 2016
- Microparticle-associated tissue factor activity in patients with metastatic pancreatic cancer and its effect on fibrin clot formationTranslational Research, 2014
- Cancers predispose neutrophils to release extracellular DNA traps that contribute to cancer-associated thrombosisProceedings of the National Academy of Sciences of the United States of America, 2012
- Pre-analytical and analytical variables affecting the measurement of plasma-derived microparticle tissue factor activityThrombosis Research, 2012
- Plasma tissue factor may be predictive of venous thromboembolism in pancreatic cancerJournal of Thrombosis and Haemostasis, 2008